Bicyclic heterocycles as MEK kinase inhibitors

Details for Australian Patent Application No. 2009266956 (hide)

Owner GENENTECH, INC.

Inventors Savy, Pascal Pierre; Lyssikatos, Joseph; Jackson, Philip; Heald, Robert Andrew; Price, Stephen

Agent Griffith Hack

Pub. Number AU-A-2009266956

PCT Pub. Number WO2010/003025

Priority 61/077,426 01.07.08 US

Filing date 1 July 2009

Wipo publication date 7 January 2010

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 275/04 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/003025 Priority application(s): WO2010/003025

10 March 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Dec 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009266979-Heterocyclic derivatives as modulators of ion channels

2009266953-Isoindolone derivatives as MEK kinase inhibitors and methods of use